Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma-Reference-Cited by-同舟云学术

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

Published:2011-08-24 Issue:1 Volume:53 Page:118-122
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bashir Qaiser,Shah Nina,Parmar Simrit,Wei Wei,Rondon Gabriela,Weber Donna M.,Wang Michael,Orlowski Robert Z.,Thomas Sheeba K.,Shah Jatin,Qureshi Sofia R.,Dinh Yvonne T.,Popat Uday,Anderlini Paolo,Hosing Chitra,Giralt Sergio,Champlin Richard E.,Qazilbash Muzaffar H.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.606942

Reference22 articles.

1. Hematopoietic stem cell transplantation for multiple myeloma beyond 2010

2. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

3. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

4. Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma

5. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elderly (> 70 years) Multiple Myeloma Patients Benefit Equally from Autologous Hematopoietic Stem Cell Transplantation When Compared to Younger Patients;Journal of Stem Cell Therapy and Transplantation;2024-08-08

2. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review;Journal of Geriatric Oncology;2024-04

3. Investigating the effect of pre-transplant thrombocytopenia and anemia on the engraftment and long-term survival in multiple myeloma patients;Transplant Immunology;2024-02

4. Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma;Annals of Hematology;2023-03-23

5. Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience;Cancers;2022-05-03